Homocysteine is embryotoxic but does not cause neural tube defects in mouse embryos

Anatomy and Embryology

Volumn 206, Issue 3, 2003, Pages 185-191

  Greene, Nicholas D E ^a   Dunlevy, Louisa P E ^a   Copp, Andrew J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Embryo culture; Folic acid; Neurulation; Somites; Teratogen

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; TERATOGENIC AGENT;

AMINO ACID METABOLISM; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO CULTURE; EMBRYOTOXICITY; FOLATE METABOLISM; IN SITU HYBRIDIZATION; MOUSE; NEURAL TUBE DEFECT; NEURULATION; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; SOMITE; TERATOGENICITY; YOLK SAC;

ANIMALIA;

EID: 0037295535     PISSN: 03402061     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00429-002-0284-3     Document Type: Article

References (37)

1. Bettenhausen B, De Angelis MH, Simon D, Guénet J-L, Gossler A (1995) Transient and restricted expression during mouse embryogenesis of D111, a murine gene closely related to Drosophila Delta. Development 121:2407-2418
2. Chen Z, Karaplis AC, Ackerman SL, Pogribny IP, Melnyk S, Lussier-Cacan S, Fong Chen M, Pai A, John SWM, Smith RS, Bottiglieri T, Bagley P, Selhub J, Rudnicki MA, James SJ, Rozen R (2001) Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet 10:433-443
3. Cockroft DL (1990) Dissection and culture of postimplantation embryos. In: Copp AJ, Cockroft DL (eds) postimplantation mammalian embryos: a practical approach. IRL Press, Oxford, pp 15-40
4. Czeizel AE, Dudás I (1992) Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832-1835
5. De Angelis MH, McIntyre J, Gossler A (1997) Maintenance of somite borders in mice requires the Delta homologue DI11. Nature 386:717-721
6. De Franchis R, Sebastio G, Mandato C, Andria G, Mastroiacovo P (1995) Spina bifida, 677T->C mutation, and role of folate. Lancet 346:1703
7. Dunwoodie SL, Henrique D, Harrison SM, Beddington RSP (1997) Mouse D113: A novel divergent Delta gene which may complement the function of other Delta homologues during early pattern formation in the mouse embryo. Development 124:3065-3076
8. 2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell 67:767-774
9. Eskes TKAB (1998) Neural tube defects, vitamins and homocysteine. Eur J Pediatr 157 [Suppl 2]:139-141
10. Fell D, Selhub J (1990) Disruption of thymidylate synthesis and glycine-serine interconversion by L-methionine and L-homocystine in Raji cells. Biochim Biophys Acta 1033:80-84
11. Fleming A, Copp AJ (1998) Embryonic folate metabolism and mouse neural tube defects. Science 280:2107-2109
12. Greene NDE, Copp AJ (1997) Inositol prevents folate-resistant neural tube defects in the mouse. Nat Med 3:60-66
13. Hansen DK, Grafton TF, Melnyk S, James SJ (2001) Lack of embryotoxicity of homocysteine thiolactone in mouse embryos in vitro. Reprod Toxicol 15:239-244
14. Heid MK, Bills ND, Hinrichs SH, Clifford AJ (1992) Folate deficiency alone does not produce neural tube defects in mice. J Nutr 122:888-894
15. 12 are independent risk factors for neural tube defects. Q J M 86:703-708
16. Kusumi K, Sun ES, Kerrebrock AW, Bronson RT, Chi D, Bulotsky MS, Spencer JB, Birren BW, Frankel WN, Lander ES (1998) The mouse pudgy mutation disrupts Delta homologue DII3 and initiation of early somite boundaries. Nat Genet 19:274-278
17. Mills JL, Tuomilehto J, Yu KF, Colman N, Blaner WS, Koskela P, Rundle WE, Forman M, Toivanen L, Rhoads GG (1992) Maternal vitamin levels during pregnancies producing infants with neural tube defects. Eur J Pediatr 120:863-871
18. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, Scott JM (1995) Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345:149-151
19. Ou CY, Stevenson RE, Brown VK, Schwartz CE, Allen WP, Khoury MJ, Rozen R, Oakley GP, Jr. Adams MJ, Jr (1996) 5,10 methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 63:610-614
20. Papapetrou C, Lynch SA, Burn J, Edwards YH (1996) Methylenetetrahydrofolate reductase and neural tube defects. Lancet 348:58
21. Rosenquist TH, Ratashak SA, Selhub J (1996) Homocysteine induces congenital defects of the heart and neural tube: Effect of folic acid. Proc Natl Acad Sci USA 93:15227-15232
22. Scott J, Weir DG, Kirke PN (1994) Prevention of neural tube defects with folic acid a success. QJM 87:705-707
23. Scott JM, Weir DG, Molloy A, McPartlin J, Daly L, Kirke P (1994) Folic acid metabolism and mechanisms of neural tube defects. In: Bock G, Marsh J (eds) Neural tube defects (Ciba Foundation Symposium 181). John Wiley & Sons, Chichester, pp 180-187
24. Selhub J (1999) Homocysteine metabolism. Annu Rev Nutr 19:217-26
25. Shields DC, Kirke PN, Mills JL, Ramsbottom D, Molloy AM, Burke H, Weir DG, Scott JM, Whitehead AS (1999) The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 64:1045-55
26. Speer MC, Worley G, Mackey JF, Melvin E, Oakes WJ, George TM (1997) The thermolabile variant of methylenetetrahydrofolate reductase (MTHFR) is not a major risk factor for neural tube defect in American Caucasians. Neurogenetics 1:149-150
27. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, Finkelstein JD, Blom HJ, Thomas CMG, Borm GF, Wouters MGAJ, Eskes TKAB (1994) Maternal hyperhomocysteinemia: A risk factor for neural-tube defects. Metabolism 43:1475-1480
28. Steegers-Theunissen RP, Boers GH, Blom HJ, Nijhuis JG, Thomas CMG, Borm GF, Eskes TK (1995) Neural tube defects and elevated homocysteine levels in amniotic fluid. J Obstet Gynaecol Res 172:1436-1441
29. Steegers-Theunissen RPM, Wathen NC, Eskes TKAB, Van Raaij-Selten B, Chard T (1997) Maternal and fetal levels of methionine and homocysteine in early human pregnancy. J Obstet Gynaecol Res 104:20-24
30. Van der Put NMJ, Steegers-Theunissen RPM, Frosst P, Trijbels FJM, Eskes TKAB, Van den Heuvel LP, Mariman ECM, Den Heyer M, Rozen R, Blom HJ (1995) Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071
31. 12 metabolism in families with spina bifida offspring. QJM 90:505-510
32. VanAerts LAGJM, Klasboer HH, Postman S, Pertijs JCLM, Copius Peereboom-Stegeman JHJ, Eskes TKAB, Noordhoek J (1993) Stereospecific in vitro embryotoxicity of L-homocysteine in pre- and post-implantation rodent embryos. Toxicol in vitro 7:743-749
33. VanAerts LAGJM, Blom HJ, Deabreu RA, Trijbels FJM, Eskes TKAB, Peereboom-Stegeman JHJC, Noordhoek J (1994) Prevention of neural tube defects by and toxicity of L-homocysteine in cultured postimplantation rat embryos. Teratology 50:348-360
34. VanAerts LAGJM, Poirot CM, Herberts CA, Blom HJ, De Abreu RA, Trijbels JMF, Eskes TKAB, Peereboom-Stegeman JHJC, Noordhoek J (1995) Development of methionine synthase, cystathionine-synthase and S-adenosyl-homocysteine hydrolase during gestation in rats. J Reprod Fertil 103:227-232
35. Wald N, Sneddon J, Densem J, Frost C, Stone R, MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet 338:131-137
36. Whitehead AS, Gallagher P, Mills JL, Kirke PN, Burke H, Molloy AM, Weir DG, Shields DC, Scott JM (1995) A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. QJM 88:763-766
37. Wilkinson DG (1992) In situ hybridisation: a practical approach. IRL Press, Oxford